| Literature DB >> 32342816 |
Maurizio Battaglia Parodi1, Pierluigi Iacono2, Stefano Da Pozzo3.
Abstract
The therapeutic approach based on anti-vascular endothelial growth factor (anti-VEGF) molecules can be used to treat two important complications of retinal dystrophies: choroidal neovascularization and macular edema. The macular involvement in retinal dystrophies can lead to further visual deterioration in patients at a young age and already affected by functional limitations. The study reports the effect of anti-VEGF treatment in several subforms of retinal dystrophies, critically discussing advantages and limitations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Choroidal neovascularization; anti-VEGF; best vitelliform macular dystrophy; macular edema retinitis pigmentosa; pattern dystrophy; stargardtzzm321990disease
Year: 2020 PMID： 32342816 DOI： 10.2174/1389450121666200428103334
Source DB: PubMed Journal: Curr Drug Targets ISSN： 1389-4501 Impact factor: 3.465